Related Experiment Video
Updated: May 1, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Pertussis vaccine performance in an epidemic year-Oregon, 2012
Juventila Liko1, Steve G Robison1, Paul R Cieslak2
1Oregon Immunization Program.
Abstract:
A 2012 pertussis epidemic in Oregon afforded an opportunity to measure vaccine effectiveness; it ranged from 95% (95% confidence interval [CI], 92%-97%) among children 15-47 months of age to 47% (95% CI, 19%-65%) among adolescents 13-16 years of age. In all age groups, pertussis incidence was higher among unimmunized persons.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Vaccinations
Diphtheria
Infectious Diseases and Their Occurrence
Principles of Disease Surveillance
Influenza
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...